ARTICLE | Company News
Biocon Ltd, Mylan deal
July 6, 2009 7:00 AM UTC
The partners will develop and commercialize follow-on biologics, specifically mAbs and other complex biologics. The companies will share profits and the cost of development, capital and certain other ...